The India-EU Free Trade Agreement opens access to the European Union's $572.3 billion pharmaceuticals and medical devices ...

SK Capital Partners have signed a definitive agreement to divest the Noramco API related assets in a sale to Siegfried (Zofingen Switzerland) -- The transaction is subject to customary closing ...

Stakeholders said regulatory alignment, safeguards against unfair competition, and how patient safety is protected will ...

These three stocks stand out not only because of their relatively low valuations, but also because of promising growth ...

Textile, footwear, electronics to gems and jewellery, FTA serves as a gateway to unprecedented market access, granting over ...

The deal will reduce tariffs on pharmaceutical exports from Europe to India to zero from 11% for almost all products. This will also reduce input costs for specialized raw material that Indian firms ...

PMMI research identifies top manufacturing hurdles including regulatory compliance, automation needs, and sustainability priorities ...

For much of the past decade, drug shortages in the United States were treated as episodic disruptions. In 2024, that framing ...

Regulatory authorities in China have cracked down on Sun Pharma’s rivastigmine-based Alzheimer’s disease treatment, halting ...

Multiply Labs' goal is to enable scalable, high-throughput manufacturing while maintaining rigorous quality and regulatory standards.

PMMI research shows pharmaceutical manufacturers face a growing market and will need OEMs and suppliers to overcome ...

The plant, announced in May 2025, was slated to open in the first quarter of this year, bringing 170 jobs to Plano’s Legacy ...